Switching Between Second-Generation Antipsychotics: Why and How?

Author： Monika Edlinger   Susanne Baumgartner   Nadja Eltanaihi-Furtmüller   Martina Hummer   W. Wolfgang Fleischhacker  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.19, Iss.1, 2005-01, pp. : 27-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Second-Generation Antipsychotics: Is There Evidence for Sex Differences in Pharmacokinetic and Adverse Effect Profiles?

By Aichhorn Wolfgang   Whitworth Alexandra B.   Weiss Elisabeth M.   Marksteiner Josef  

Drug Safety, Vol. 29, Iss. 7, 2006-01 ,pp. : 587-598

Adis International

Access to resources Recommend Favorite

Relationship between P-glycoprotein and second-generation antipsychotics

By Moons Tim   de Roo Mariska   Claes Stephan   Dom Geert  

Pharmacogenomics, Vol. 12, Iss. 8, 2011-08 ,pp. : 1193-1211

Future Medicine

Access to resources Recommend Favorite

Second-generation antipsychotic AE monitoring adequate?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 650, 2012-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Second-generation antipsychotic AE monitoring adequate?

By  

Reactions Weekly, Vol. 1, Iss. 1395, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Biological Therapy in the Management of Recent-Onset Crohn's Disease: Why, When and How?

By Löwenberg Mark  

Drugs, Vol. 66, Iss. 11, 2006-01 ,pp. : 1431-1439

Adis International

Access to resources Recommend Favorite